Poster: Shi, Y.; Zhang, Q.; Han, X.; Song, Y.; Qin, Y.; Hong, X.; Ke, X.; Feng, J.; Wang, D.; Li, W.; Su, H.; Zhang, Y.; Zhang, H.; Yang, J.; Liu, L.; Zhang, X.; Liu, E.; Jiang, W.; Liu, S.; Luk, A., 286PFirst china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics). Annals of Oncology 2018, 29 (suppl_9), mdy437.005-mdy437.005.
